A U.S. court upheld the convictions of Theranos’ founder Elizabeth Holmes and President Ramesh “Sunny” Balwani on Monday, on charges of defrauding investors in the failed blood testing startup once valued at $9 billion.
A three-judge panel for the 9th U.S. Circuit Court of Appeals in San Francisco rejected claims of legal errors at their separate trials held in 2022.
